Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1995
08/17/1995WO1995021860A1 Methods for variation of chromatin condensation
08/17/1995WO1995021859A1 Cytotoxic factor associated with disseminated sclerosis, its detection and quantification
08/17/1995WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021856A1 Carbamoylmethylurea derivative
08/17/1995WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021629A1 Oral delivery of chemically modified proteins
08/17/1995WO1995021626A1 Methods for stimulating erythropoiesis using thrombopoietin
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021624A1 High-concentration aureobasidin preparation in solution form
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021611A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
08/17/1995WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995WO1995021527A1 Stem cell engraftment
08/17/1995WO1995016040A3 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
08/17/1995WO1995014465A3 Methods for amelioration of immunodeficiency virus induced neurodegeneration by covering nitric oxide or superoxide concentration
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2183069A1 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2183063A1 Prostaglandin i2 receptor
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182494A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995CA2182493A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995CA2182310A1 Pp32: a newly identified cd45-associated protein
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/17/1995CA2181986A1 Carbamoylmethylurea derivatives
08/17/1995CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995CA2160591A1 Protein having tpo activity
08/16/1995EP0667395A1 Monoclonal antibody, process for producing the same, and use thereof
08/16/1995EP0667355A1 Hirudin derivatives and process for their preparation
08/16/1995EP0667354A1 Multiple sclerosis associated cytotoxic factor, its detection and quantification
08/16/1995EP0667353A1 Glycopeptide antibiotic derivatives
08/16/1995EP0667352A1 Process for the removal of prions in collagens and collagens thus obtained
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
08/16/1995EP0667164A1 Use of hydrolytic enzyme for reducing or preventing side effects of bleomycine
08/16/1995EP0667163A1 Powder for nasal administration of peptidic or proteinaceous drug
08/16/1995EP0667145A1 Stabilized cosmetic or dermatologic composition containing several precursors of a same active agent
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
08/16/1995EP0666920A1 Thrombin activatable plasminogen derivatives
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666911A1 Multidrug resistance gene
08/16/1995EP0666869A1 Peptides tolerizing t-cells and compositions thereof
08/16/1995EP0666868A1 Vascular endothelial cell growth factor antagonists
08/16/1995EP0666867A1 Reagents and methods for treating rheumatoid arthritis
08/16/1995EP0666866A1 Method of isolating biomolecules by ion exchange
08/16/1995EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
08/16/1995EP0666842A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
08/16/1995EP0666759A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders
08/16/1995EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
08/16/1995EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
08/16/1995EP0666756A1 Method of producing analgesia using neurotrophins
08/16/1995EP0666755A1 Inhibitiion of retrovirus infection
08/16/1995EP0666754A1 Synthetic lung surfactant having antioxidant properties
08/16/1995EP0666753A1 Method for the treatment of the complications and pathology of diabetes
08/16/1995EP0666752A1 Therapeutic microemulsions
08/16/1995EP0666749A1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
08/16/1995EP0666745A1 Diagnosis and therapy for parkinson's disease
08/16/1995EP0666740A1 Thiol compounds for strengthening the immune system and immune reactions
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995EP0527809B1 Walk-through mutagenesis
08/16/1995EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides
08/16/1995EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases
08/16/1995CN1106980A Anti-aids immunomodulator complex
08/16/1995CN1106819A Tripeptide antithrombotic agents
08/16/1995CN1106699A Long-noded pit viper injection and preparing process thereof
08/16/1995CN1106698A Prolonged delivery of peptides
08/15/1995US5442053 Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions
08/15/1995US5442050 Isolated DNA sequences
08/15/1995US5442049 Viricides
08/15/1995US5442044 Orally active renin inhibitors
08/15/1995US5442008 Stabilized polymer film coated compounds and stabilized formulations in compressed from using same
08/15/1995US5441960 1-pyrimidinylacetamide human leukocyte elastate inhibitors
08/15/1995US5441944 Substituted cyclodextrin sulfates and their uses as growth modulating agents
08/15/1995US5441937 Neurotrophic factor
08/15/1995US5441936 Treatment of herpes simplex
08/15/1995US5441935 Polypeptide for treatment of small cell lung cancer in humans
08/15/1995US5441933 Containing diluent, lubricant, disintegrating agent and/or binder
08/15/1995US5441931 Human amyloid protein precursor homologue and Kunitz-type inhibitors
08/15/1995US5441883 A3 adenosine receptor, DNA, and uses
08/15/1995US5441875 Urea transporter polypeptide
08/15/1995US5441871 Monoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995US5441739 Reduced and controlled surface binding of biologically active molecules
08/15/1995US5441737 Use of apotransferrin that has bound zinc or copper ions for treatment of toxic effects of endotoxins
08/15/1995US5441734 Crystalline zinc interferon alpha-2 having monoclinic morphology and specified x-ray diffraction analysis
1 ... 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 ... 3163